Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 1: Discovery and initial structure–activity relationships for 1-amino-2-phenyl-4-(piperidin-1-yl)butanes
- 26 January 2001
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 11 (2) , 259-264
- https://doi.org/10.1016/s0960-894x(00)00637-5
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Human Chemokines: An UpdateAnnual Review of Immunology, 1997
- Chemokine Receptors and HIV-1: An Attractive Pair?Cell, 1996
- The β-Chemokine Receptors CCR3 and CCR5 Facilitate Infection by Primary HIV-1 IsolatesPublished by Elsevier ,1996
- CC CKR5: A RANTES, MIP-1α, MIP-1β Receptor as a Fusion Cofactor for Macrophage-Tropic HIV-1Science, 1996
- A Dual-Tropic Primary HIV-1 Isolate That Uses Fusin and the β-Chemokine Receptors CKR-5, CKR-3, and CKR-2b as Fusion CofactorsCell, 1996
- Reductive Amination of Aldehydes and Ketones with Sodium Triacetoxyborohydride. Studies on Direct and Indirect Reductive Amination Procedures1The Journal of Organic Chemistry, 1996
- Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8 + T CellsScience, 1995
- In vivo emergence of HIV-1 variants resistant to multiple protease inhibitorsNature, 1995
- A facile synthesis of the novel Neurokinin A antagonist SR 48968Bioorganic & Medicinal Chemistry Letters, 1993
- The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brainCell, 1986